Mitochondrial DNA mutations in oral squamous cell carcinoma: A systematic review and meta-analysis
Open Access
- 1 July 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 30 (3) , 426-433
Abstract
Oral squamous cell carcinoma (OSCC) accounts for more than 90% of oral malignancies globally and remains a major health burden in South and Southeast Asia. Emerging evidence implicates mitochondrial dysfunction and mitochondrial DNA (mtDNA) mutations in OSCC carcinogenesis, progression, and prognosis. This systematic review and meta-analysis aimed to determine the pooled prevalence of mtDNA mutations in OSCC, map recurrent mutational hotspots, and evaluate their diagnostic and prognostic relevance. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, PubMed, Scopus, Web of Science, and EMBASE were searched (2000–2025) for observational studies analysing somatic mtDNA mutations in OSCC. Risk of bias was assessed using the Joanna Briggs Institute (JBI) checklist for prevalence studies, and a DerSimonian–Laird random-effects proportional meta-analysis was performed. Subgroup analyses explored coding versus noncoding mutations, D-loop hotspots, and heteroplasmic versus homoplasmic patterns. Eight studies comprising 403 patients were included. The pooled prevalence of mtDNA mutations in OSCC was 88.1% (95% CI: 69.9–99.1). Individual study prevalence ranged from 26.7% (Yuan et al .) to 100% (Fendt, Kloss-Brandstätter, Mondal (b), and Palodhi). Heterogeneity was high (I² = 94.9%, Cochran’s Q = 137.97, P < 0.001; τ² = 0.3467). In the leave-one-out sensitivity analysis, the pooled prevalence ranged from 84.5% to 93.6%. These findings indicate that mtDNA mutations are highly prevalent in OSCC, although heterogeneity is considerable; larger standardised studies are needed to establish their diagnostic and prognostic value.Keywords
This publication has 14 references indexed in Scilit:
- Profiling of genomic alterations of mitochondrial DNA in gingivobuccal oral squamous cell carcinoma: Implications for disease progressMitochondrion, 2019
- Altered expression of mitochondrial antioxidants in oral squamous cell carcinomaJournal of Oral Science, 2017
- Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell CarcinomaPLOS ONE, 2015
- Impact of Somatic Mutations in the D-Loop of Mitochondrial DNA on the Survival of Oral Squamous Cell Carcinoma PatientsPLOS ONE, 2015
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal CancersJournal of Clinical Oncology, 2013
- Mitochondrial DNA Mutation in Normal Margins and Tumors of Recurrent Head and Neck Squamous Cell Carcinoma PatientsCancer Prevention Research, 2010
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Mitochondrial DNA mutations in oral squamous cell carcinomaCarcinogenesis, 2006
- Mitochondrial genome variation and the origin of modern humansNature, 2000
- Sequence and organization of the human mitochondrial genomeNature, 1981